Govt weighs stricter norms, heavy fines in draft Drugs and Cosmetics Act2 min read . Updated: 05 Oct 2016, 05:01 AM IST
Consistent violations of Good Manufacturing Practices may invite not just suspension of drug licences, but also stiff fines and jail time for executives
New Delhi: The government is considering measures, including imposing heavy fines and imprisonment, in the draft Drugs and Cosmetics Act to prevent pharmaceutical companies from violating manufacturing norms, according to two health ministry officials .
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more